Vanta Bioscience Ltd. Announces Unaudited Standalone and Consolidated Financial Results for H1 2025

Vanta Bioscience Ltd. announced the unaudited standalone and consolidated financial results for the half year ended September 30, 2025. The standalone financial results show a revenue from operation of 30.18 Lakhs, total revenues of 36.57 Lakhs, and a net profit after tax of (0.57) Lakhs. The consolidated financial results include the interim financial statements of a subsidiary with total assets of 393.75 Lakhs, total revenues of Nil, total net profit after tax of (0.57) Lakhs, and cash flows (net outflow) of Nil for the period from April 1, 2025 to September 30, 2025. The Board of Directors approved these results in a meeting held on November 14, 2025.